IMPLANT SITE WARMTH

This adverse event was reported 155 times

These drugs are most commonly taken by patients reporting IMPLANT SITE WARMTH:

# Drug Count
0 ETONOGESTREL 90
1 BACLOFEN 17
2 HYDROMORPHONE HYDROCHLORIDE 7
3 BACLOFEN INJECTION 6
4 CARBAMAZEPINE 5
5 GABAPENTIN 5
6 IBUPFROFEN 4
7 IBUPROFEN 4
8 IBUPROFEN 200 MG 4
9 IBUPROFEN 200MG 4
See all common drugs associated with IMPLANT SITE WARMTH

IMPLANT SITE WARMTH is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BACLOFEN INJECTION 6 0.0019
1 ETONOGESTREL 90 0.0016
2 ZICONOTIDE ACETATE 3 0.0012
3 HISTRELIN ACETATE 1 0.0011
4 METHAMPHETAMINE HYDROCHLORIDE 1 0.0009
5 TOLNAFTATE 1 0.0008
6 NARATRIPTAN 1 0.0007
7 IBRITUMOMAB TIUXETAN 1 0.0007
8 IPRATROPIUM BROMIDE AND ALBUTEROL 1 0.0004
9 CALCITONIN SALMON 1 0.0003
See all drugs enriched for association with IMPLANT SITE WARMTH

IMPLANT SITE WARMTH is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Calcitonin [EPC] 1 0.0003
1 Progestin [EPC] 90 0.0003
2 gamma-Aminobutyric Acid-ergic Agonist [EPC] 22 0.0002
3 Androgen [EPC] 3 0.0001
4 Interleukin-31 Receptor alpha Antagonist [EPC] 1 0.0001
5 Cholinesterase Inhibitor [EPC] 1 0.0001
6 Alkaloid [EPC] 1 0.0000
7 Central alpha-2 Adrenergic Agonist [EPC] 2 0.0000
8 Amide Local Anesthetic [EPC] 3 0.0000
9 Provitamin D2 Compound [EPC] 1 0.0000
See all drug classes enriched for association with IMPLANT SITE WARMTH